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ABSTRACT
Purpose: Sphingolipid metabolites, such as sphingosine
and ceramide, are highly bioactive compounds and are in-
volved in diverse cell processes, including cell-cell interac-
tion, cell proliferation, differentiation, and apoptosis. How-
ever, the physiological roles of phytosphingosine are poorly
understood. In this study, we report that phytosphingosine
can potently induce apoptotic cell death in human cancer
cells via caspase activation and caspase-independent cyto-
chrome c release.
Experimental Design: Phytosphingosine-induced apo-
ptosis was determined by Hoechst 33258 staining, flow cy-
tometric analysis, and DNA fragmentation assay. Involve-
ment of caspases was determined by immunoblot analysis
and cell death detection assays after treatment with
synthetic inhibitor z-Val-Ala-Asp-fluoromethyl ketone, z-
DEVD-fmk, or z-IETD-fmk. Death receptor (DR) depend-
ency was analyzed by examining expression of DRs (Fas,
DR4, DR5, TNFR1, and R2), and interaction of Fas-associ-
ated death domain and caspase 8. Involvement of the mito-
chondria pathway was examined by monitoring of the mi-
tochondria membrane potential, cytochrome c release, and
Bax translocation.
Results: Phytosphingosine-treated cells displayed sev-
eral features of apoptosis, including increase of sub-G1 pop-
ulation, DNA fragmentation, and poly(ADP-ribose) polym-
erase cleavage. We observed that phytosphingosine cause
activation of caspase 8 in a DR-independent fashion. Phyto-
sphingosine also induced activation of caspase 9 and 3, loss
of mitochondrial membrane potential, and the cytochrome c
release from mitochondria. However, we failed to detect Bid
cleavage. Moreover, caspase 8 inhibitor z-IETD-fmk did not
affect phytosphingosine-induced cytochrome c release and
caspase 9 activation, suggesting that phytosphingosine-
induced cytochrome c release is caused by caspase 8-inde-
pendent manner. Phytosphingosine induced mitochondrial
translocation of Bax from the cytosol without changes in the
protein levels of Bcl-2, Bcl-xL, and Bax. In addition, Bcl-2/
Bax interaction was diminished after addition of phyto-
sphingosine.
Conclusion: These findings indicate that phytosphin-
gosine induces apoptotic cell death in human cancer cells by
direct activation of caspase 8, and by mitochondrial trans-
location of Bax and subsequent release of cytochrome c into
cytoplasm, providing a potential mechanism for the antican-
cer activity of phytosphingosine.
INTRODUCTION
Two major cellular apoptotic pathways have been estab-
lished that mediate apoptosis on exposure to different types of
stimuli, such as anticancer drug, ionizing radiation, and viruses
(1). One, which is activated by the most anticancer drugs,
involves the disruption of mitochondrial membrane potential
that leads to the release of cytochrome c, which can trigger
caspase 9. The other is activated by the ligation of DRs3 (1)
including TNF receptor gene superfamily. On activation, the
DRs recruit the adaptor molecule FADD by the death domain
that is also present on FADD, followed by the activation of
caspase 8 (2, 3).
Caspase 8 directly activates downstream caspase, caspase
3. Caspase 9, which is activated after the release of cytochrome
c from mitochondria, can also activate caspase 3 (2). The
mitochondrial activation-mediated pathway has been shown to
be required for Fas-induced apoptosis in certain cell types that
are classified as type II cells. In these cells, Bid, “BH3 only”
protein of the Bcl-2 family, mediates the release of cytochrome
c from mitochondria initiated by caspase 8 activation. The
release of cytochrome c and other apoptogenic factors from
injured mitochondria have been shown to activate caspases (4),
and the mitochondrial integrity appears to be regulated, in part,
by members of the Bcl-2 family. In response to apoptotic
signals, Bax, a proapoptotic member of this family, is redistrib-
uted from the cytosol to the mitochondria, where it decreases
Received 5/31/02; revised 9/3/02; accepted 9/11/02.
The costs of publication of this article were defrayed in part by the
payment of page charges. This article must therefore be hereby marked
advertisement in accordance with 18 U.S.C. Section 1734 solely to
indicate this fact.
1 Supported by Nuclear R&D Program from the Ministry of Science and
Technology in Korea.
2 To whom requests for reprints should be addressed, at Laboratory of
Radiation Effect, Korea Cancer Center Hospital Gongneung-Dong,
Nowon-Ku, Seoul 139-706, Korea. Phone: 82-2-970-1324; Fax: 82-2-
977-0381. E-mail: sjlee@kcchsun.kcch.re.kr.
3 The abbreviations used are: DR, death receptor; FADD, Fas-associated
death domain; TNF, tumor necrosis factor; PARP, poly(ADP-ribose)
polymerase; DiOC6(3), 3,3dihexylocarbocyanine iodide; PI, propidium
iodide; FBS, fetal bovine serum.
878 Vol. 9, 878–885, February 2003 Clinical Cancer Research
Research. 
on July 14, 2014. © 2003 American Association for Cancerclincancerres.aacrjournals.org Downloaded from 
membrane potential leading to cytochrome c release and caspase
activation (5).
Recent discoveries have revealed that sphingolipids (cer-
amide, sphingosine, sphingosine 1-phosphate, phytosphin-
gosine, and so forth) are highly bioactive compounds and are
involved in diverse cell processes (6, 7). Ceramide and sphin-
gosine are generated by sphingomyelinase-mediated hydrolysis
of sphingomyelin, which resides in the plasma membrane (8). A
variety of exogenous stimuli, such as TNF-, anti-Fas antibody,
IL-1, and -radiation, rapidly increase intracellular levels of
ceramide and sphingosine through sphingomyelinase, leading to
modulation of various cellular events, including apoptosis, pro-
liferation, and differentiation (8–10). Phytosphingosine is also
one of the most widely distributed natural sphingoid bases,
which is abundant in fungi and plants, and also found in animals
including humans. Phytosphingosine is structurally similar to
sphingosine; phytosphingosine possesses a hydroxyl group at
C-4 of the sphingoid long-chain base, whereas sphingosine has
a trans-double bond between C-4 and C-5. However, the phys-
iological roles of phytosphingosine are largely unknown, al-
though recent reports show that phytosphingosine exerts strong
cytotoxic effects on Chinese hamster ovary cells and modulates
the muscarinic acetylcholine receptor-mediated signal transduc-
tion pathway (11).
In this study, we investigated the cellular mechanisms of
cell death in human cancer cells induced by phytosphingosine.
We report here that phytosphingosine induces apoptotic cell
death in human cancer cells both by caspase-dependent and
-independent pathways. Our data provide a potential mechanism
for the anticancer activity of phytosphingosine and suggest that
phytosphingosine may have therapeutic potential for the treat-
ment of human cancer.
MATERIALS AND METHODS
Cell Culture. Jurkat, human T-cell lymphoma (type II),
and NCI-H460, human non-small cell lung cancer cells, were
obtained from the American Type Culture Collection (Rock-
ville, MD). Cells were grown in PRMI 1640 supplemented with
10% FBS, penicillin, and streptomycin.
Materials. Phytosphingosine was purchased from Doo-
San Bio-Tech (Seoul, Korea). Polyclonal antibody to caspase 3
and monoclonal antibodies to PARP and cytochrome c were
obtained from PharMingen (San Diego, CA), and polyclonal
antibodies to caspase 8, 9, Bcl-2, Bax, and Bid were obtained
from Santa Cruz (Santa Cruz, CA). The caspase 3 inhibitor,
z-DEVD-fmk, the broad-spectrum caspase inhibitor, z-VAD-
fmk, and the caspase 8 inhibitor, z-IETD-fmk were obtained
from Calbiochem (San Diego, CA).
Hoechst 33258 Staining. Hoechst 33258 staining was
performed as described previously (12). Briefly, cells were fixed
with 4% paraformaldehyde for 30 min in room temperature and
then washed once with PBS. Hoechst 33258 (50 ng/ml) was
added to the fixed cells, incubated for 30 min at room temper-
ature, and washed with PBS. Cells were mounted and examined
by fluorescence microscopy. Apoptotic cells were identified by
the condensation and fragmentation of their nuclei. The percent-
age of apoptotic cells was calculated from the ratio of apoptotic
cells to total cells counted. At minimum, 500 cells were counted
for each treatment.
Flow Cytometric Analysis of Apoptosis. Apoptosis was
identified and quantified by flow cytometry with PI staining.
Both adherent and floating cells were collected after phyto-
sphingosine treatment, washed with ice-cold PBS, and fixed
with 70% ice-cold ethanol overnight at 4°C. Fixed cells were
washed twice with PBS and treated with 1 mg/ml RNase for 30
min at 37°C. Cellular DNA was stained with 50 g/ml PI in
PBS containing 0.05% NP40. Cells were then analyzed by
FACScan flow cytometer (Becton Dickinson, Franklin Lakes,
NJ). From the analysis of DNA histograms, the percentages of
cells in different cell cycle phases were evaluated. Cells with
DNA content less than the G1 phase (sub-G1) were taken as
apoptotic cells.
Extration of DNA and Agarose Gel Electrophoresis.
Cells were treated with 5 or 10 g/ml phytosphingosine and
were lysed in a lysis buffer [20 mM Tris-HCl (pH 8.0), 0.1 mM
EDTA, 1% SDS, and 0.5 mg/ml proteinase K]. DNA samples
were extracted and separated by agarose gel electrophoresis.
Western Blot Analysis. Western blot analysis was per-
formed as described (13). Briefly, cell lysates were prepared by
extracting proteins with lysis buffer [40 mM Tris-HCl (pH 8.0),
120 mM NaCl, and 0.1% NP40] supplemented with protease
inhibitors. Proteins were separated by SDS-PAGE and trans-
ferred to nitrocellulose membrane. The membrane was blocked
with 5% nonfat dry milk in Tris-buffered saline and then incu-
bated with primary antibodies for 1 h at room temperature. Blots
were developed by peroxidase-conjugated secondary antibody,
and proteins were visualized by enhanced chemiluminescence
procedures (NEN) according to the manufacturer’s recommen-
dation (Boston, MA).
Measurement of Mitochondrial Membrane Potential.
Mitochondrial membrane potential was determined as the reten-
tion of the mitochondria-specific dye DiOC6(3). Cells were
loaded with 30 nM DiOC6(3) during the last 30 min of phyto-
sphingosine treatment. After removal of the medium, the cells
were washed twice with PBS, and the concentration of retained
DiOC6(3) was measured by flow cytometric analysis.
Preparation of Cytosolic and Mitochondrial Fractions
for Cytochrome c and Bax Translocation Measurement.
Cells were collected and washed twice in ice-cold PBS, resus-
pended in S-100 buffer [20 mM HEPES (pH 7.5), 10 mM KCl,
1.9 mM MgCl2, 1 mM EGTA, 1 mM EDTA, and a mixture of
protease inhibitors] and incubated on ice for 20 min. After a
20-min incubation on ice, the cells were homogenized with a
glass Dounce and a loose pestle (Wheaton, Millville, NJ) for 70
strokes. Cell homogenates were spun at 1,000  g to remove
unbroken cells, nuclei, and heavy membranes. The supernatant
was respun at 14,000  g for 30 min to collect the mitochon-
dria-rich (the pellet) and the cytosolic (the supernatant) frac-
tions. The mitochondria-rich fraction was washed once with the
extraction buffer, followed by a final resuspension in lysis
buffer [150 mM NaCl, 50 mM Tris-Cl (pH 7.4), 1% NP40, 0.25%
sodium deoxycholate, and 1 mM EGTA] containing protease
inhibitors for Western blot analysis.
Immunofluorescence Analysis. For immunofluores-
cence analysis, cells were fixed with 2% paraformaldehyde,
permeabilized with 0.1% Triton X-100 in PBS, incubated with
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25 nM Mitotracker Red CMXRos (Molecular Probes, Inc., Eu-
gene, OR) for 30 min at room temperature, and then washed
three times with PBS. Cells were then incubated with rabbit
antihuman Bax diluted 1:200 in 5% FBS/PBS for 1 h at room
temperature in a humidified chamber. Excess antibody was
removed by washing the coverslips three times with PBS. Cells
were then incubated with biotin-labeled goat antirabbit IgG
(Zymed Laboratories Inc.) diluted 1:200 in 5% FBS/PBS, and
for 1 h protected from light at room temperature. After washing
three times with PBS, cells were incubated with FITC-strepta-
vidin diluted 1:200 in 5% FBS/PBS for 4 h. After washing three
times with PBS, coverslips were mounted onto microscope
slides using ProLong antifade mounting reagent (Molecular
Probes). The slides were analyzed by a confocal laser-scanning
microscope (Leica Microsystems).
RESULTS
Phytosphingosine Induces Apoptosis in Human T-Cell
Lymphoma and Non-Small Cell Lung Cancer Cells. To
determine whether phytosphingosine leads to apoptotic cell
death in type II cells, Jurkat and NCI-H460 cells were treated
with different doses of phytosphingosine, and apoptotic cell
death was analyzed by Hoechst 33258 staining, flow-cytometric
cell death analysis, and DNA laddering. Fig. 1A shows that there
is a dose- and a time-dependent increase of apoptotic cells after
phytosphingosine treatment, as measured by Hoechst 33258
staining of nuclei fragmentation and condensation. Apoptosis in
Jurkat cells were additionally confirmed by flow-cytometric
analysis of cellular DNA contents after staining with PI (Fig.
1B). Phytosphingosine treatment increased cells with sub-G1
contents of DNA, reaching 75% of the total Jurkat cells after
6 h of the treatment (10 g/ml). Furthermore, phytosphingosine
treatment resulted in internucleosomal DNA fragmentation in
Jurkat cells, as evidenced by the formation of a DNA ladder in
agarose gel (Fig. 1C). Taken together, these results demonstrate
that phytosphingosine induces apoptotic cell death in human
T-cell lymphoma and non-small cell lung cancer cells in a dose-
and time-dependent manner.
Requirement of Caspase Activities during Phytosphin-
gosine-induced Apoptosis. To determine the requirement of
caspase activities during phytosphingosine-induced apoptosis of
type II Jurkat and NCI-H460 cells, we used Western blot anal-
ysis to analyze the activation of various caspases (Fig. 2A).
Treatment of cells with 5 M phytosphingosine caused activa-
Fig. 1 Phytosphingosine induces apoptosis in human T-cell lymphoma and lung carcinoma cells. A, Jurkat and NCI-H460 cells were treated with
various concentrations of phytosphingosine for the times indicated. Cells were stained with Hoechst 33258, and apoptotic cells were measured by
observation under a fluorescence microscope. Apoptotic cells, which contained condensed chromatin fragments, were scored and expressed as a
percentage of the total cell number measured. Results from three independent experiments are shown as means; bars, SE. B, Jurkat cells were treated
with 5 or 10 g/ml of phytosphingosine for the times indicated. Apoptotic cells were measured by flow cytometric analysis after PI staining. The
figure shows a representative result of three independent experiments with similar results. C) Jurkat cells were treated with 5 or 10 g/ml of
phytosphingosine for the time indicated. DNA samples were extracted from cells, subjected to agarose gel electrophoresis, stained with ethidium
bromide, and visualized under UV light.
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tion of caspase 8 in a time-dependent manner, as indicated by
reduction in the intensity of the proenzyme. Activation of the
caspase 9 by the phytosphingosine was also evidenced by the
reduction in the intensity of the proenzyme. Activated caspase-3
was detected after phytosphingosine treatments as a double band
representing a p19 proteolytic fragment and the active subunit
p17, respectively. In addition, phytosphingosine caused a
marked increase in cleavage products of PARP. In NCI-H460
cells, we could not detect cleaved form of caspase 3, and PARP.
However, the decrease in proform enzymes was consistently
observed. Caspase activation during the course of phytosphin-
gosine-induced apoptosis was additionally confirmed by using a
broad-spectrum caspase inhibitor, z-VAD-fmk, and a caspase
3-specific inhibitor, z-DEVD-fmk. As expected, these caspase
inhibitors were able to prevent activation of caspases (Fig. 2B)
and attenuate apoptosis (Fig. 2C), suggesting that phytosphin-
gosine-induced apoptotic cell death is largely dependent on
caspase activation.
Phytosphingosine-induced Caspase 8 Activation Is In-
dependent on DRs. On the basis of the requirement of
caspase activities, we first presumed that phytosphingosine in-
duce apoptotic cell death through DR-mediated caspase 8 acti-
vation. However, we failed to detect induction of Fas, TNF-
related apoptosis inducing ligand receptors (DR4 and DR5), and
TNF receptors (TNFR1 and R2) in Jurkat cells treated with
phytosphingosine (Fig. 3A). Furthermore, treatment of phyto-
sphingosine did not affect interaction between FADD and
caspase 8 (Fig. 3B), strongly suggesting that phytosphingosine-
induced caspase 8 activation in these cells occurs in a DR-
independent fashion.
Phytosphingosine Induces Caspase-independent Cyto-
chrome c Release from Mitochondria. To evaluate the con-
tribution of the mitochondrial pathway to the induction of ap-
optosis seen after phytosphingosine treatment, we examined
changes in mitochondrial membrane potential and cytochrome c
release into the cytosol in the phytosphingosine-treated type II
Fig. 2 Requirement of caspase
activities during phytosphin-
gosine-induced apoptosis. A, Ju-
rkat and NCI-H460 cells were
treated with 5 or 10 g/ml of
phytosphingosine for the times
indicated. Cell lysates were pre-
pared and assessed by Western
blot analysis for caspase 3, -8, -9,
and PARP. B, Jurkat cells were
treated with 5 g/ml of phyto-
sphingosine for the times indi-
cated in the presence or absence
of 30 M z-DEVD-fmk or 30 M
z-VAD-fmk. Cell lysates were
prepared and assessed Western
blot analysis for caspase-8, -9, -3,
and PARP. The data represent a
typical experiment conducted at
least three times with similar re-
sults. C, Jurkat cells were treated
with 5 g/ml of phytosphin-
gosine for the times indicated in
the presence or absence of 30 M
z-DEVD-fmk or 30 M z-VAD-
fmk. Cells were stained with Ho-
echst 33258 dye and observed
under a fluorescence microscope.
Apoptotic cells were determined
as described in the “Materials
and Methods.” Results represent
means of three independent ex-
periment; bars, SE.
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Jurkat cells. Fig. 4A shows that phytosphingosine treatment
significantly disrupted mitochondrial membrane potential. At
the same time, the level of cytosolic cytochrome c was markedly
increased (Fig. 4B), coinciding with the changes in mitochon-
drial membrane potential. Caspase 8 has been reported to cleave
Bid in type II cells in the presence of apoptotic stimuli. The
truncated Bid then triggers the mitochondrial release of cyto-
chrome c into the cytosol and activates caspase-9 (14). To
investigate whether caspase 8 activation mediated by phyto-
sphingosine precedes cytochrome c release, we examined Bid
cleavage after phytosphingosine treatment. Fig. 4B shows that
phytosphingosine did not cause any changes in Bid cleavage in
type II Jurkat cells, suggesting that Bid is not involved in
cytochrome c release after phytosphingosine treatment. As ex-
pected, however, treatment of anti-Fas antibody to the Jurkat
cells caused a marked Bid cleavage as well as caspase 8 acti-
vation (Fig. 4C). These results suggest that Bid cleavage is not
involved in phytosphingosine-induced cytochrome c release.
We next examined the effect of specific caspase inhibitors on
phytosphingosine-induced cytochrome c release. Fig. 4, D and E
shows that the broad caspase inhibitor, z-VAD-fmk, and caspase
8 specific inhibitor, z-IETD-fmk, did not prevent the accumu-
lation of cytochrome c in the cytosol of phytosphingosine-
treated cells, suggesting that a caspase-independent pathway
is involved in cytochrome c release after phytosphingosine
treatment.
Phytosphingosine-induced Cell Death Involves Alter-
ations in the Intracellular Redistribution of Bax Protein.
Because it has been shown that translocation of Bax from the
cytosol to the mitochondria causes caspase activation, a decline
of mitochondrial membrane potential and subsequent cyto-
chrome c release (15), we investigated whether phytosphin-
gosine treatment induces mitochondrial translocation of Bax.
Fig. 5, A and B, shows that phytosphingosine treatment (5 M)
dramatically redistributes Bax from cytosol to the mitochondria
without changing the protein expression levels of Bcl-2, Bcl-xL,
and Bax. Indirect immunofluorescence staining of Bax clearly
indicated its translocation to the mitochondria (Fig. 5C). In
addition, Bax/Bcl-2 interaction was markedly decreased after
addition of phytosphingosine (Fig. 5D). These results are con-
sistent with previous data on Bax translocation in several dif-
ferent cell types in response to distinct forms of cell death
stimuli (16). To test whether redistribution of Bax protein occurs
in a caspase-independent manner, we examined the effect of
specific caspase inhibitors on phytosphingosine-induced Bax
translocation. The addition of the caspase inhibitors failed to
prevent the intracellular redistribution of Bax (data not shown).
These results suggest that phytosphingosine induces redistribu-
tion of the Bax protein to the mitochondria in a caspase-inde-
pendent manner during the progression of apoptosis.
DISCUSSION
This study was undertaken to characterize the potential
mechanism for the anticancer activity of phytosphingosine. The
functional mechanism of anticancer activity of sphingosine has
been studied extensively. However, despite structural similarity,
the physiological roles of phytosphingosine are largely un-
known. In this study, we found that phytosphingosine induces
apoptotic cell death in human cancer cells through a direct
pathway from caspase 8 activation and caspase-independent
release of cytochrome c after intracellular redistribution of cell
death activator Bax.
Phytosphingosine induces apoptotic cell death in type II
Jurkat, a human T-cell lymphoma cell line, and in NCI-H460, a
human non-small cell lung cancer cell line, in a concentration-
and a time-dependent manner. In the presence of caspase inhib-
itors, phytosphingosine-induced apoptosis was almost com-
Fig. 3 Phytosphingosine does not affect the
expression of DRs and the interaction between
FADD and caspase 8. Jurkat cells were treated
with 5 g/ml of phytosphingosine for 3 h. A,
expressions of Fas, TNF-related apoptosis in-
ducing ligand (DR4 and DR5), and TNF re-
ceptors (R1 and R2) were examined by flow
cytometry after staining the cells with anti-
Fas, -DR4, -DR5, TNF R1, and R2 antibodies
(diluted at 1:200). B, cell lysates were immu-
noprecipitated with anti-FADD antibody and
separated on SDS-polyacrylamide gels, trans-
ferred to nitrocellulose, and immunoblotted
with anti-caspase 8 antibody. The data repre-
sent a typical experiment conducted three
times with similar results.
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pletely suppressed, suggesting that phytosphingosine-induced
apoptosis is largely dependent on caspase activities. We ob-
served that phytosphingosine cause the activation of caspase 8.
However, we failed to detect changes in the expression of DRs
(Fas, DR4, DR5, TNFR1, and R2), and the interaction between
FADD and caspase 8 after treatment of phytosphingosine. This
suggests that phytosphingosine-mediated caspase 8 activation
and apoptosis are independent of DRs and/or FADD. It has been
reported recently that anticancer drugs induce apoptosis and
caspase 8 cleavage in a FADD-independent manner, suggesting
that DR activation is not prerequisite for drug-induced caspase
8 activation (17). The nature of the adaptor molecules capable of
mediating caspase 8 oligomerization and cleavage remains to be
determined. Nevertheless, our data are consistent with the
emerging hypothesis that caspase 8 activation is not restricted
to DRs.
Caspase 8 activity is often responsible for the cleavage of
a cytosolic substrate, e.g., Bid, which triggers the release of
cytochrome c from mitochondria in type II cells (18). Interest-
ingly, we found that phytosphingosine-induced caspase 8 acti-
vation is not correlated with Bid cleavage in type II Jurkat cells.
However, phytosphingosine did induce a decrease in mitochon-
drial membrane potential, cytochrome c release into cytosol, and
activation of caspase-9. Furthermore, caspase-8 specific inhib-
itor, N-benzyloxycarbonyl-IETD-fmk, did not inhibit these
events, strongly suggesting that phytosphingosine-induced cy-
Fig. 4 Phytosphingosine in-
duces caspase-independent cyto-
chrome c release from mitochon-
dria. A, mitochondrial membrane
potential was determined as the
retention of the mitochondria-
specific dye DiOC6(3). Jurkat
cells were loaded with 30 nM
DiOC6(3) during the last 30 min
of phytosphingosine treatment.
After removal of the medium,
the concentration of retained
DiOC6(3) was measured by flow
cytometric analysis. B, Jurkat
cells were treated with 5 g/ml
of phytosphingosine for 3 and
6 h. Whole cell and cytosolic ex-
tracts were prepared and assessed
by Western blot analysis for cy-
tochrome c and Bid. The data
represent a typical experiment
conducted at least three times
with similar results. C, Jurkat
cells were treated with 50 ng/ml
of anti-Fas antibody for 3 h. Cell
lysates were prepared and as-
sessed by Western blot analysis
for caspase-8, -9, -3, and Bid.
The data represent a typical ex-
periment conducted three times
with similar results. D, Jurkat
cells were treated with 5 g/ml
phytosphingosine for 3 h in the
presence or absence of z-VAD-
fmk. Cytosolic extracts were pre-
pared and assessed by Western
blotting for cytochrome c. The
data represent a typical experi-
ment conducted three times with
similar results. E, Jurkat cells
were treated with 5 g/ml phyto-
sphingosine for 3 h in the pres-
ence or absence of z-IETD-fmk.
Whole cell and cytosolic extracts
were prepared and assessed by
Western blotting for caspase 8,
Bid, cytochrome c, and caspase
9. The data represent a typi-
cal experiment conducted three
times with similar results.
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tochrome c release from the mitochondria and caspase-9 acti-
vation are not associated with caspase-8 activation. Thus, it is
possible that phytosphingosine-induced cytochrome c release
may be initiated by another cytosolic factor(s) other than Bid.
On the other hand, caspase-8 specific inhibitor z-IETD-fmk
significantly blocked phytosphingosine-induced caspase 3 acti-
vation and apoptosis, which correlates well with the previous
reports showing that caspase 8 directly activates caspase 3.
Bax translocation to the mitochondria has been shown to
reduce mitochondrial membrane potential, enhance cytochrome
c release from the mitochondria, and activate caspases (16). Our
data show that phytosphingosine induced Bax translocation
from the cytosol to the mitochondria without changing the
protein levels of the Bax and Bcl-2. We also show that phyto-
sphingosine markedly decreases the level of Bcl-2/Bax com-
plex, suggesting that Bax might be released from Bcl-2/Bax
complex by unknown mechanism. Recent data demonstrated
that even slight structural modification, such as phosphoryla-
tion, can alter function(s) of Bcl-2 as an antiapoptotic molecule
(19). In fact, Bcl-2 phosphorylation may cause either disruption
of the intermolecular cooperation or increased susceptibility to
the protein degradation mediated by intracellular proteolytic
enzyme (19). However, we do not know exactly which mole-
cules are involved in the modification of Bcl-2 and/or translo-
cation of Bax protein at this point. Additional studies will be
necessary to identify the exact mechanism of regulation of
Bcl-2/Bax modulation and Bax translocation induced by phyto-
sphingosine treatment.
Taken together, these results suggest that phytosphingosine
induces apoptotic cell death in human cancer cells through
caspase 8 activation and caspase-independent cytochrome c
release mediated by Bax translocation to the mitochondria. We
believe that this is the first report on the potential mechanism for
the anticancer activity of phytosphingosine.
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fraction was prepared, and Bax was detected by Western blot analysis using anti-Bax antibody. The data represent a typical experiment conducted
four times with similar results. C, cells were treated with 5 g/ml of phytosphingosine for 3 h. Cells were incubated with Mitotracker and stained
with anti-Bax antibody. The slides were analyzed by a confocal laser scanning microscope. Mitochondrial localization of Bax was defined by yellow
spots indicating overlap of FITC and Mitotracker. D, Jurkat cells were treated with 5 g/ml of phytosphingosine for 3 h. Cell lysates were
immunoprecipitated with anti-Bcl-2 antibody and separated on SDS-polyacrylamide gels, transferred to nitrocellulose, and incubated with anti-Bax
antibody. The data represent a typical experiment conducted three times with similar results.
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